STAAR Surgical (NASDAQ: STAA) reported Q1 EPS of ($1.10), $0.52 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $42.6 million versus the consensus estimate of $40.33 million.

Outlook

The Company announced that it is withdrawing the financial outlook previously provided on February 11, 2025.

“Global economic uncertainty and evolving tariff policy make it more challenging to forecast. As a result, despite confidence in our recent efforts to mitigate tariff exposure and our optimism regarding both short-term and long-term business trends, we are withdrawing the Company’s previous financial outlook,” concluded Mr. Farrell.

For earnings history and earnings-related data on STAAR Surgical (STAA) click here.